다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Ovid Therapeutics Inc (OVID)
Ovid Therapeutics Inc (OVID) 뉴스

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/29	23:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/17	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/17	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/12/02	22:00	GlobeNewswire Inc.	Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/11/12	22:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/10/31	21:00	GlobeNewswire Inc.	Ovid Therapeutics to Host Investor Event	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/26	21:00	GlobeNewswire Inc.	Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	06:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	06:36	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/12	05:57	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/11	21:00	GlobeNewswire Inc.	Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth	NASDAQ:OVID	Ovid Therapeutics Inc
2024/09/04	21:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at Upcoming September Investor Conferences	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/13	21:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/08	21:00	GlobeNewswire Inc.	Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development Officer	NASDAQ:OVID	Ovid Therapeutics Inc
2024/08/03	06:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/07/30	21:00	GlobeNewswire Inc.	Ovid Therapeutics to Present at Upcoming August Investor Conferences	NASDAQ:OVID	Ovid Therapeutics Inc
2024/07/23	21:00	GlobeNewswire Inc.	Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists	NASDAQ:OVID	Ovid Therapeutics Inc
2024/07/10	21:00	GlobeNewswire Inc.	eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant Seizures	NASDAQ:OVID	Ovid Therapeutics Inc
2024/07/01	21:00	GlobeNewswire Inc.	Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations	NASDAQ:OVID	Ovid Therapeutics Inc
2024/06/17	20:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/06/17	19:55	GlobeNewswire Inc.	Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for Soticlestat	NASDAQ:OVID	Ovid Therapeutics Inc
2024/06/08	05:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/15	06:19	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OVID	Ovid Therapeutics Inc
2024/05/14	21:00	GlobeNewswire Inc.	Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results	NASDAQ:OVID	Ovid Therapeutics Inc

검색 관련기사 보기:NASDAQ:OVID

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

Gold vs US Dollar

JP Morgan Chase

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관